News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,579 Results
Type
Article (765)
Company Profile (1)
Press Release (7813)
Multimedia
Podcasts (7)
Webinars (1)
Section
Business (3093)
Career Advice (16)
Deals (388)
Drug Delivery (8)
Drug Development (1299)
Employer Resources (3)
FDA (261)
Job Trends (159)
News (4639)
Policy (357)
Tag
2027 Biotech Bay Standard (1)
40 Under 40 (1)
Academia (31)
Accelerated approval (4)
ADA (3)
Alliances (961)
ALS (3)
Alzheimer's disease (19)
Antibody-drug conjugate (ADC) (12)
Approvals (267)
Artificial intelligence (18)
ASCO (3)
Autoimmune disease (7)
Automation (2)
Bankruptcy (10)
Belgium (2)
Best Places to Work (94)
BIOSECURE Act (1)
Biosimilars (20)
BioSpace Insights (2)
Biotechnology (1)
Bladder cancer (1)
Breast cancer (9)
Cancer (106)
Cardiovascular disease (12)
Career advice (15)
CDMO (3)
Cell therapy (7)
Clinical research (1123)
Collaboration (86)
Compensation (5)
COVID-19 (14)
CRO (1)
C-suite (33)
Cystic fibrosis (7)
Data (97)
Depression (1)
Dermatology (3)
Diabetes (13)
Diagnostics (49)
Digital health (5)
Drug discovery (6)
Drug pricing (22)
Earnings (820)
Editorial (1)
Employer branding (1)
Employer resources (2)
ESMO (1)
Events (865)
Executive appointments (27)
FDA (301)
Frontotemporal dementia (1)
Funding (38)
Generative AI (3)
Gene therapy (10)
GLP-1 (78)
Government (63)
Guidances (7)
Healthcare (143)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (1)
Immunology and inflammation (10)
Immuno-oncology (1)
Indications (4)
Infectious disease (18)
Inflammatory bowel disease (6)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (2)
Interviews (4)
IPO (179)
IRA (10)
Job creations (69)
Job search strategy (15)
Kidney disease (7)
Labor market (2)
Layoffs (13)
Legal (83)
Licensing (3)
Lung cancer (42)
Lung diease (2)
Machine learning (2)
Management (1)
Manufacturing (18)
Marketing (1)
MASH (17)
Medical device (76)
Medtech (79)
Melanoma (2)
Mergers & acquisitions (201)
Metabolic disorders (71)
mRNA (5)
Multiple sclerosis (1)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (4)
Neuroscience (45)
NextGen: Class of 2026 (70)
Non-profit (36)
Now hiring (1)
Obesity (50)
Opinion (8)
Ovarian cancer (1)
Pain (1)
Parkinson's disease (3)
Patents (5)
Patient selection (2)
People (1003)
Pharmacy benefit managers (3)
Phase 1 (265)
Phase 2 (456)
Phase 3 (423)
Pipeline (179)
Policy (19)
Postmarket research (115)
Preclinical (87)
Rare diseases (20)
Real estate (74)
Recruiting (1)
Regulatory (290)
Reports (1)
Research institute (30)
Resumes & cover letters (1)
RNA editing (1)
Schizophrenia (10)
Series A (10)
Series B (6)
Special edition (1)
Startups (62)
Supply chain (2)
The Weekly (7)
Vaccines (12)
Venture capital (5)
Weight loss (39)
Date
Last 7 days (5)
Last 30 days (49)
Last 365 days (361)
2026 (341)
2025 (318)
2024 (413)
2023 (371)
2022 (665)
2021 (669)
2020 (584)
2019 (520)
2018 (377)
2017 (536)
2016 (489)
2015 (451)
2014 (374)
2013 (333)
2012 (325)
2011 (309)
2010 (336)
Location
Africa (20)
Alabama (1)
Arizona (4)
Asia (279)
Australia (66)
California (305)
Canada (13)
China (15)
Colorado (2)
Connecticut (32)
Europe (2336)
Florida (2)
Georgia (11)
Illinois (11)
India (2)
Indiana (12)
Japan (8)
Kansas (1)
Maryland (2)
Massachusetts (65)
Michigan (6)
Missouri (1)
Nevada (1)
New Hampshire (1)
New Jersey (16)
New York (19)
North Carolina (7)
Northern California (74)
Ohio (1)
Oklahoma (1)
Oregon (1)
Pennsylvania (11)
South America (21)
Southern California (177)
Tennessee (1)
Texas (7)
United States (523)
Utah (1)
Virginia (1)
Washington D.C. (2)
Washington State (18)
8,579 Results for "boehringer ingelheim fremont".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two other Phase 1 studies this year.
August 24, 2026
·
1 min read
·
Tristan Manalac
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
Envisagenics’ platform makes use of AI to screen and detect cancer-specific RNA alterations, which Boehringer Ingelheim wants to target through various precision treatment modalities, including multi-specific antibodies, antibody-drug conjugates and T cell engagers.
September 22, 2026
·
2 min read
·
Tristan Manalac
Obesity
Boehringer, Zealand’s obesity drug doesn’t elevate heart risk in key late-stage test
The Phase 3 results help clarify the safety profile of Zealand and Boehringer Ingelheim’s survodutide, but analysts do not think the drug will find utility beyond patients with liver-related risk factors.
November 9, 2026
·
4 min read
·
Annalee Armstrong
Deals
Boehringer bets big on China, offering $7B biobucks for Sino cancer programs
Boehringer Ingelheim is building up its China strategy, inking a deal to develop new cancer treatments with Sino Biopharmaceutical just weeks after opening an R&D facility in Shanghai.
November 4, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
November 1, 2026
·
6 min read
Press Releases
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies
· New research team expands capabilities at Boehringer’s U.S. R&D site in Ridgefield, Connecticut.
July 9, 2026
·
1 min read
Press Releases
Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies
November 4, 2026
·
5 min read
Press Releases
Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development
October 22, 2026
·
4 min read
Press Releases
AimedBio and Boehringer Ingelheim initiate Phase I study of antibody-drug conjugate BI 4060107
October 26, 2026
·
2 min read
Press Releases
Boehringer Ingelheim Spotlights Next Generation of Veterinary Researchers
August 10, 2026
·
5 min read
1 of 858
Next